Global Blood Screening Market By Product Type (Reagent, Instrument) And By End-Users/Application (Blood Bank, Hospital) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Blood Screening market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Blood Screening market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Blood Screening industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Blood Screening ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Blood Screening market.

The following manufacturers are covered in this report:
  • Abbott Laboratories
  • Abbott
  • Apex Biotechnology Corp.
  • Beckman Coulter (A Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company
  • Biomrieux
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche
  • Grifols
  • Hem

The report estimates on the Blood Screening market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Blood Screening market report consist of all leading industry players, Blood Screening business sections, company profile, revenue supply by Blood Screening industry sections, global Blood Screening market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Blood Screening market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Blood Screening market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Blood Screening market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Blood Screening market.

Report Opportunity: Global Blood Screening Market

This report delivers an analytical examination of the Blood Screening market summarized in broad sections such as
  1. Blood Screening Market Summary
  2. Key Commercial Growths in the Blood Screening Industry
  3. Market Dynamics Affecting the Blood Screening Industry
  4. Important Market Trends and Future Development Scenario of the Blood Screening Market
  5. Blood Screening Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Blood Screening Industry
  7. Positioning of Main Market Players in the Blood Screening Industry
  8. Blood Screening Market Revenue and Forecast, by Application, 2018 - 2028
  9. Blood Screening Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Blood Screening Market Revenue and Forecast, by Geography, 2018 - 2028
Blood Screening Market Segmentation:

The report provides detailed examination of the Blood Screening market on the basis of various segments such as type, application and end-use industry. The Blood Screening market is segmented as follows:

Blood Screening Market, by Type:
  • Reagent
  • Instrument
Blood Screening Market, by Application:
  • Blood Bank
  • Hospital
Geographic Coverage

The report on the Blood Screening market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Blood Screening Market Revenue and Forecast
  • U.S.
  • Canada
Europe Blood Screening Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Blood Screening Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Blood Screening Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Blood Screening Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Blood Screening Market Snapshot
          2.1.1. Global Blood Screening Market By Type,2019
               2.1.1.1.Reagent
               2.1.1.2.Instrument
          2.1.2. Global Blood Screening Market By Application,2019
               2.1.2.1.Blood Bank
               2.1.2.2.Hospital
          2.1.3. Global Blood Screening Market By End-use,2019
          2.1.4. Global Blood Screening Market By Geography,2019

3. Global Blood Screening Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Blood Screening Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Blood Screening Market Size (US$), By Type, 2018 – 2028

5. Global Blood Screening Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Blood Screening Market Size (US$), By Application, 2018 – 2028

6. Global Blood Screening Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Blood Screening Market Size (US$), By End-use, 2018 – 2028

7. Global Blood Screening Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Blood Screening Market Analysis, 2018 – 2028 
          7.2.1. North America Blood Screening Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Blood Screening Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Blood Screening Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Blood Screening Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Blood Screening Market Analysis, 2018 – 2028 
          7.3.1.  Europe Blood Screening Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Blood Screening Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Blood Screening Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Blood Screening Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Blood Screening Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Blood Screening Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Blood Screening Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Blood Screening Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Blood Screening Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Blood Screening Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Blood Screening Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Blood Screening Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Blood Screening Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Blood Screening Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Blood Screening Market Analysis, 2018 – 2028 
          7.6.1.  MEA Blood Screening Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Blood Screening Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Blood Screening Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Blood Screening Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Blood Screening Providers
        8.4.1 Abbott Laboratories
                8.1.1 Business Description
                8.1.2 Abbott Laboratories Geographic Operations
                8.1.3 Abbott Laboratories Financial Information
                8.1.4 Abbott Laboratories Product Positions/Portfolio
                8.1.5 Abbott Laboratories Key Developments
        8.4.2 Abbott
                8.2.1 Business Description
                8.2.2 Abbott Geographic Operations
                8.2.3 Abbott Financial Information
                8.2.4 Abbott Product Positions/Portfolio
                8.2.5 Abbott Key Developments
        8.4.3 Apex Biotechnology Corp.
                8.3.1 Business Description
                8.3.2 Apex Biotechnology Corp. Geographic Operations
                8.3.3 Apex Biotechnology Corp. Financial Information
                8.3.4 Apex Biotechnology Corp. Product Positions/Portfolio
                8.3.5 Apex Biotechnology Corp. Key Developments
        8.4.4 Beckman Coulter (A Subsidiary of Danaher Corporation)
                8.4.1 Business Description
                8.4.2 Beckman Coulter (A Subsidiary of Danaher Corporation) Geographic Operations
                8.4.3 Beckman Coulter (A Subsidiary of Danaher Corporation) Financial Information
                8.4.4 Beckman Coulter (A Subsidiary of Danaher Corporation) Product Positions/Portfolio
                8.4.5 Beckman Coulter (A Subsidiary of Danaher Corporation) Key Developments
        8.4.5 Becton, Dickinson and Company
                8.5.1 Business Description
                8.5.2 Becton, Dickinson and Company Geographic Operations
                8.5.3 Becton, Dickinson and Company Financial Information
                8.5.4 Becton, Dickinson and Company Product Positions/Portfolio
                8.5.5 Becton, Dickinson and Company Key Developments
        8.4.6 Biomrieux
                8.6.1 Business Description
                8.6.2 Biomrieux Geographic Operations
                8.6.3 Biomrieux Financial Information
                8.6.4 Biomrieux Product Positions/Portfolio
                8.6.5 Biomrieux Key Developments
        8.4.7 Bio-Rad Laboratories, Inc.
                8.7.1 Business Description
                8.7.2 Bio-Rad Laboratories, Inc. Geographic Operations
                8.7.3 Bio-Rad Laboratories, Inc. Financial Information
                8.7.4 Bio-Rad Laboratories, Inc. Product Positions/Portfolio
                8.7.5 Bio-Rad Laboratories, Inc. Key Developments
        8.4.8 F. Hoffmann-La Roche
                8.8.1 Business Description
                8.8.2 F. Hoffmann-La Roche Geographic Operations
                8.8.3 F. Hoffmann-La Roche Financial Information
                8.8.4 F. Hoffmann-La Roche Product Positions/Portfolio
                8.8.5 F. Hoffmann-La Roche Key Developments
        8.4.9 Grifols
                8.9.1 Business Description
                8.9.2 Grifols Geographic Operations
                8.9.3 Grifols Financial Information
                8.9.4 Grifols Product Positions/Portfolio
                8.9.5 Grifols Key Developments
        8.4.10 Hem
                8.10.1 Business Description
                8.10.2 Hem Geographic Operations
                8.10.3 Hem Financial Information
                8.10.4 Hem Product Positions/Portfolio
                8.10.5 Hem Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Blood Screening Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Blood Screening Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Blood Screening Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Blood Screening Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Blood Screening Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Blood Screening Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Blood Screening Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Blood Screening Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Blood Screening Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Blood Screening Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Blood Screening Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Blood Screening Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Blood Screening Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Blood Screening Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Blood Screening Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Blood Screening Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Blood Screening: Market Segmentation 
FIG. 2 Global Blood Screening Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Blood Screening Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Blood Screening Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Blood Screening Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Blood Screening Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Blood Screening Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Blood Screening Providers, 2019
FIG. 11 Global Blood Screening Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Blood Screening Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Blood Screening Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Blood Screening Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Blood Screening Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Blood Screening Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Blood Screening Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Blood Screening Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Blood Screening market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1138

7400

OUR CLIENT